WST West Pharmaceutical RESULTS: Q2, Q2 net sales $872.3M vs. EST $838.6M, Q2 EPS $2.15, West Pharmaceutical Earnings Notes:, - West Pharmac
WST West Pharmaceutical RESULTS: Q2, Q2 net sales $872.3M vs. EST $838.6M, Q2 EPS $2.15, West Pharmaceutical Earnings Notes:, - West Pharmaceutical Q2 ADJ EPS $2.37 vs. EST $2.08, Outlook FY net sales $3,345-3.380B vs. EST $3.332B, Outlook FY ADJ EPS $8.85-9.05 vs. EST $8.61, Outlook FY ADJ EPS $8.85-9.05, Guides Q3 2026 net sales to $820-$835M, Guides Q3 2026 adj-diluted EPS to $2.14-$2.24
WST West Pharmaceutical RESULTS: Q2, Q2 net sales $872.3M vs.
EST $838.6M, Q2 EPS $2.15, West Pharmaceutical Earnings Notes:, - West Pharmaceutical Q2 ADJ EPS $2.37 vs.
EST $2.08, Outlook FY net sales $3,345-3.380B vs.
EST $3.332B, Outlook FY ADJ EPS $8.85-9.05 vs.
EST $8.61, Outlook FY ADJ EPS $8.85-9.05, Guides Q3 2026 net sales to $820-$835M, Guides Q3 2026 adj-diluted EPS to $2.14-$2.24